創維數字(000810.SZ):子公司以9188萬元競得惠州地塊 滿足未來發展對研發、製造用地的需求
格隆匯 5 月 10日丨創維數字(000810.SZ)公佈,近日,惠州創維數字以人民幣9188萬元競得了掛牌編號為GZK2021-33號地塊的國有建設用地使用權,並於2021年5月8日與惠州市公共資源交易中心仲愷分中心簽訂了《惠州仲愷高新區國有建設用地使用權網上掛牌交易成交確認書》。
地塊位置:惠州仲愷高新技術產業開發區陳江街道;宗地總面積:138165㎡(其中使用權面積為112642㎡);土地用途:工業用地;土地使用權出讓年限:50年。
惠州創維數字此次競拍取得上述國有建設用地使用權,將有效滿足公司未來發展對研發、製造用地的需求,有利於優化公司產業佈局,符合公司戰略發展規劃和長遠發展目標。此次購買土地使用權不影響現有主營業務的正常開展,不會對公司財務狀況及經營成果產生重大影響,不存在損害上市公司及全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.